{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Title: Randomised Controlled Trial Comparing Recurrence Rates of Diabetic Foot Ulcers and Chronic Limb-Threatening Ischaemia to Advanced-Stage Cancers"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Participants": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Intervention": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aimed to compare the 3-year recurrence rates of diabetic foot ulcers (DFU) and the rate of endovascular reintervention for chronic limb-threatening ischaemia (CLTI) to recurrence rates of advanced-stage cancers."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the 3-year recurrence rate."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "The pooled 3-year DFU recurrence rate was 58%, while the CLTI reintervention rate was 50%. These rates are comparable to cancer recurrence rates: breast (25%-40%), prostate (30%-40%), colorectal (30%-50%), and lung (60%-80%)."
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: Not provided."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not provided."
      }
    },
    "total_score": 6,
    "max_score": 25
  },
  "model": "gpt-4o"
}